Berliner Boersenzeitung - US panel recommends Covid vaccines for youngest children

EUR -
AED 3.824989
AFN 71.402285
ALL 97.627614
AMD 406.436125
ANG 1.885525
AOA 951.312422
ARS 1045.555022
AUD 1.601982
AWG 1.877095
AZN 1.792548
BAM 1.944948
BBD 2.112314
BDT 125.022417
BGN 1.95415
BHD 0.392523
BIF 3090.415867
BMD 1.041384
BND 1.405883
BOB 7.228735
BRL 6.044613
BSD 1.046163
BTN 88.392
BWP 14.28265
BYN 3.423796
BYR 20411.134706
BZD 2.108833
CAD 1.457595
CDF 2988.773459
CHF 0.925666
CLF 0.036821
CLP 1015.74547
CNY 7.547747
CNH 7.560467
COP 4570.896582
CRC 531.832553
CUC 1.041384
CUP 27.596687
CVE 109.654219
CZK 25.355594
DJF 186.300506
DKK 7.457947
DOP 63.038268
DZD 139.856872
EGP 51.722338
ERN 15.620766
ETB 130.374134
FJD 2.369514
FKP 0.821982
GBP 0.832337
GEL 2.83779
GGP 0.821982
GHS 16.634346
GIP 0.821982
GMD 73.938043
GNF 9017.770456
GTQ 8.076016
GYD 218.88082
HKD 8.106803
HNL 26.437866
HRK 7.428465
HTG 137.356236
HUF 410.848543
IDR 16577.798642
ILS 3.868967
IMP 0.821982
INR 87.938151
IQD 1370.572407
IRR 43847.491348
ISK 145.460334
JEP 0.821982
JMD 166.150118
JOD 0.73844
JPY 160.751742
KES 134.855838
KGS 90.075475
KHR 4219.537432
KMF 489.086083
KPW 937.245587
KRW 1464.275008
KWD 0.320534
KYD 0.871848
KZT 518.822617
LAK 22916.13564
LBP 93689.742622
LKR 304.391597
LRD 188.840865
LSL 18.930456
LTL 3.074937
LVL 0.629923
LYD 5.110485
MAD 10.46312
MDL 19.050703
MGA 4898.784029
MKD 61.522855
MMK 3382.375986
MNT 3538.624216
MOP 8.387422
MRU 41.607245
MUR 48.78866
MVR 16.089607
MWK 1814.121361
MXN 21.290157
MYR 4.652385
MZN 66.542097
NAD 18.930547
NGN 1761.064649
NIO 38.291823
NOK 11.553218
NPR 141.426922
NZD 1.783773
OMR 0.400907
PAB 1.046163
PEN 3.973927
PGK 4.211541
PHP 61.381801
PKR 290.794744
PLN 4.336537
PYG 8211.184342
QAR 3.814254
RON 4.975319
RSD 117.003721
RUB 107.225744
RWF 1437.513665
SAR 3.909599
SBD 8.715887
SCR 14.183524
SDG 626.39872
SEK 11.548105
SGD 1.403286
SHP 0.821982
SLE 23.519696
SLL 21837.315606
SOS 597.889811
SRD 36.870228
STD 21554.555025
SVC 9.154055
SYP 2616.509459
SZL 18.938783
THB 35.940782
TJS 11.142091
TMT 3.655259
TND 3.309764
TOP 2.439029
TRY 35.987528
TTD 7.101478
TWD 33.93278
TZS 2767.332256
UAH 43.193134
UGX 3865.469096
USD 1.041384
UYU 44.582103
UZS 13386.996842
VES 48.187714
VND 26482.405897
VUV 123.635251
WST 2.907119
XAF 652.332861
XAG 0.033321
XAU 0.000386
XCD 2.814394
XDR 0.798066
XOF 652.317288
XPF 119.331742
YER 260.243298
ZAR 18.792105
ZMK 9373.707307
ZMW 28.849032
ZWL 335.32536
  • NGG

    1.0796

    63.16

    +1.71%

  • RIO

    -0.3500

    62.22

    -0.56%

  • RBGPF

    -0.5000

    59.69

    -0.84%

  • GSK

    0.1600

    33.86

    +0.47%

  • RYCEF

    0.1800

    6.79

    +2.65%

  • CMSC

    0.0600

    24.7

    +0.24%

  • BTI

    0.2000

    37.18

    +0.54%

  • AZN

    1.7500

    66.01

    +2.65%

  • RELX

    0.7800

    46.54

    +1.68%

  • VOD

    0.1173

    8.715

    +1.35%

  • JRI

    0.0310

    13.261

    +0.23%

  • BCE

    0.0950

    26.775

    +0.35%

  • BP

    -0.0010

    29.519

    -0%

  • BCC

    3.0350

    143.395

    +2.12%

  • CMSD

    0.0550

    24.5

    +0.22%

  • SCS

    0.2700

    13.31

    +2.03%

US panel recommends Covid vaccines for youngest children
US panel recommends Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel recommends Covid vaccines for youngest children

A panel of experts convened by the US Food and Drug Administration unanimously recommended Covid-19 vaccines Wednesday for children under five, the final age group awaiting immunization in most countries.

Text size:

Formal authorizations should follow soon, with the first shots in arms expected early next week, just over a year-and-a-half after the first Covid vaccines were greenlighted for the elderly in December 2020.

"This recommendation does fill a significant unmet need for a really ignored younger population," said Michael Nelson, a professor of medicine at the University of Virginia, one of the 21 experts asked to vote for the milestone meeting.

Unlike regulators in other countries, FDA offers livestreams of its internal deliberations and its stamp of approval is considered the global gold standard.

Opening the discussion, senior FDA scientist Peter Marks said that despite studies showing the majority of children have now been infected with the coronavirus, the high rate of hospitalizations among infants, toddlers and young children during last winter's Omicron wave underscored an urgent need for vaccination.

"We are dealing with an issue where we have to be careful we don't become numb to the pediatric deaths because of the overwhelming number of older deaths," he said.

"Every life is important and vaccine-preventable deaths are something we would like to try to do something about."

The United States has recorded 480 Covid deaths in the 0-4 age group in the pandemic -- far higher than even a bad flu season, Marks said.

As of May 2022, there have been 45,000 hospitalizations in that group, nearly a quarter of which required intensive care.

Ahead of the meeting, the FDA posted its independent analyses of the pharmaceutical companies' vaccines, deeming both safe and effective.

Both vaccines are based on messenger RNA, which delivers genetic code for the coronavirus spike protein to human cells that then grow it on their surface, training the immune system to be ready. The technology is now considered the leading Covid vaccination platform.

Pfizer sought authorization for three doses at three micrograms given to children aged six months through four years, while Moderna asked for the FDA to authorize its vaccine as two doses of a higher 25 micrograms for ages six months through five years.

Both vaccines were tested in trials of thousands of children. They were found to cause similar levels of mild side effects as in older age groups and triggered similar levels of antibodies.

- Two doses, or three? -

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent, compared to Moderna's estimates of 51 percent for children aged six-months to two years old and 37 percent for those aged two to five years.

But the Pfizer figure is based on very few cases and is thus considered preliminary. It also takes three doses to achieve its protection, with the third shot given eight weeks after the second, which is given three weeks after the first.

Moderna's vaccine should provide strong protection against severe disease after two doses, given four weeks apart, and the company is studying adding a booster that would raise efficacy levels against mild disease.

However, Moderna's decision to go with a higher dose is associated with higher levels of fevers in reaction to the vaccine compared to Pfizer.

There are some 20 million US children aged four years and under.

Although obesity, neurological disorders and asthma are associated with increased risk of severe disease among young children, it's not easy to predict severe outcomes.

In fact, 64 percent of hospitalizations in those under five occurred in patients without comorbidities.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition. Some three to six percent can experience long Covid symptoms for more than 12 weeks.

The FDA is expected to soon act on the panel's recommendation, and the matter will go to the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of 10 million shots at pharmacies and doctors' offices could begin as soon as June 21.

(K.Müller--BBZ)